Tumor markers

Price of Tumor marker tests for men: 91 500 HUF

Package discount: 5.2 %
Type of tests 2 pcs
Number of tests 18 pcs
Időpontfoglalás

Our Tumor marker tests can help identify different types of tumors that most commonly affect men. The package includes laboratory measurements of tumor markers that are elevated in liver, stomach, lung, large intestine (colon), prostate, and testicular lesions.

Description:

Our Tumor marker tests can help identify different types of tumors that most commonly affect men. The package includes laboratory measurements of tumor markers that are elevated in liver, stomach, lung, large intestine (colon), prostate, and testicular lesions.
Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!

A negative result does not exclude the presence of a tumor!

These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver, ovarian and testicular cancer. Among the test parameters, cancer antigen 19-9 (CA-19-9) may indicate pancreatic, bile duct, colon, lung, or gallbladder tumor. Elevated cancer antigen 50 (CA-50) may be the sign of gastrointestinal tumors. CA 72-4 is parameter to monitor the disease progression and the treatment of patients with gastric and ovarian cancer.

β-2-microglobulin (B2M) is produced by the body’s immune system (B lymphocytes) or by tumor cells. It can also be used to diagnose certain kidney diseases (glomerular dysfunction). Its level is elevated in tumors affecting the hematopoietic system (multiple myeloma, lymphoma, B-cell chronic lymphocytic leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma) as well as the testes.

The carcinoembryonic antigen (CEA) is produced by embryonic and tumor cells. Its level can be elevated in gastrointestinal tumors or in breast, lung, liver, pancreatic and ovarian cancers. In non-small cell lung cancer (mainly squamous cell and large cell carcinoma subtypes), CYFRA 21 1 is considered the most suitable biomarker.

In women, Human Chorionic Gonadotropin (hCG) is produced in placental cells and plays a role in the maintenance of the corpus luteum during pregnancy. Its elevated level may indicate pancreatic or testicular tumors.

Lactoferrin is an iron-binding protein that is also present in neutrophil granulocytes involved in the inflammatory immune response. Thus, its level correlates with inflammatory processes in gastrointestinal diseases. Its level may also be elevated in colorectal tumors.

Calprotectin is a calcium-, zinc- and manganese-binding protein produced by neutrophil granulocytes and monocytes. Its level may also be elevated in colorectal tumors.

Prostate-specific antigen (PSA) is produced by the epithelial cells of the prostate gland. PSA levels higher than 10 ng/ml are likely to indicate the presence of prostate cancer. For screening, the free PSA fraction and the total PSA/free PSA ratio are evaluated. Free PSA levels are lower in prostate cancer and higher in prostate enlargement. Annual PSA screening is recommended for people over 45 years of age, as early diagnosis of malignant prostate cancer is curable.

The measurement of neuron-specific enolase (NSE) can be used to monitor the efficacy of therapy and to assess changes in the condition of patients with tumors, particularly small-cell lung cancer and neuroblastoma.

The measurement of S-100 protein can be used to support the management of patients with malignant melanoma and to support the management of patients with brain injury (traumatic brain injury or stroke).

Chromogranin A (CgA) can be used to diagnose neuroendocrine tumors and to monitor therapy in treated patients. Neuroendocrine tumors can arise in almost any organ of the human body, most commonly arising from the mucosa of the gastrointestinal tract and pancreas, and the bronchial system. The concentration of chromogranin A correlates with disease activity and tumor size.

The SCC antigen is used for the follow-up of squamous cell carcinomas.
Pro-gastrin-releasing peptide (ProGRP) is a sensitive tumor marker of neuroendocrine cancers.

These tumor markers are not specific!

CA 19-9 levels may also be elevated in biliary cancer, pancreatitis, cystic fibrosis and liver disease.
Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, and liver cirrhosis).
CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.

Elevated CYFRA 21 1 levels have also been described in non-malignant diseases (e.g. pneumonia, sepsis) and abnormal kidney function.
High AFP levels may also be seen in hepatitis, cirrhosis and hepatitis.
β-2-microglobulin (B2M) level can be elevated in renal inflammation, autoimmune diseases (systemic lupus erythematosus (SLE)), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS), Crohn’s disease and infections (cytomegalovirus (CMV), nonA-nonB hepatitis, mononucleosis infectiosa, HIV).
PSA levels can also rise in benign prostatic enlargement (hyperplasia).
Elevated NSE levels may also occur in malignant neuroendocrine diseases, many other tumor diseases and clinical pathologies.
Chromogranin A may also be elevated in pheochromocytoma, pancreatic and prostate tumors.

Tests:

  • Tumor markers (serum test): alpha-fetoprotein (AFP), β-2-Microglobulin (B2M), cancer antigen 19-9 (CA-19-9), cancer antigen 50 (CA-50), cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA), chromagranin A (CgA), Cyfra-21-1, free β Human Chorionic Gonadotropin (free β-HCG), prostate-specific antigen (PSA), free prostate-specific antigen (PSA free), neuron-specific enolase (NSE), S-100 protein, pro-gastrin-releasing peptide (ProGRP), squamous cell carcinoma (SCC) antigen
  • Stool analysis: stool blood, lactoferrin, calprotectin

Price of Tumor markers of the male reproductive system: 23 900 HUF

Package discount: 5.50 %
Type of tests 1 pcs
Number of tests 6 pcs
Időpontfoglalás

Our Tumor marker tests can help identify different types of tumors that most commonly affect men. The package includes laboratory measurements for tumor markers that are elevated in liver, prostate, and testicular lesions as well as in neuroendocrine tumors.

Description:

Our Tumor marker tests can help identify different types of tumors that most commonly affect men. The package includes laboratory measurements for tumor markers that are elevated in liver, prostate, and testicular lesions as well as in neuroendocrine tumors.
Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!
A negative result does not exclude the presence of a tumor!
These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver, ovarian and testicular cancer.

β-2-microglobulin (B2M) is produced by the body’s immune system (B lymphocytes) or by tumor cells. It can also be used to diagnose certain kidney diseases (glomerular dysfunction). Its level is elevated in tumors affecting the hematopoietic system (multiple myeloma, lymphoma, B-cell chronic lymphocytic leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma) as well as the testes.

Elevated level of Human Chorionic Gonadotropin (hCG, free B-HCG ) may indicate pancreatic or testicular tumors in men.

Prostate-specific antigen (PSA) is produced by the epithelial cells of the prostate gland. PSA levels higher than 10 ng/ml are likely to indicate the presence of prostate cancer. For screening, the free PSA fraction and the total PSA/free PSA ratio are evaluated. Free PSA levels are lower in prostate cancer and higher in prostate enlargement. Annual PSA screening is recommended for people over 45 years of age, as early diagnosis of malignant prostate cancer is curable.

Chromogranin A (CgA) can be used to diagnose neuroendocrine tumors and to monitor therapy in treated patients. Neuroendocrine tumors can arise in almost any organ of the human body, most commonly arising from the mucosa of the gastrointestinal tract and pancreas, and the bronchial system. The concentration of chromogranin A correlates with disease activity and tumor size.

These tumor markers are not specific!

High AFP levels may also be seen in hepatitis, cirrhosis and hepatitis.
β-2-microglobulin (B2M) level can be elevated in renal inflammation, autoimmune diseases (systemic lupus erythematosus (SLE)), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS), Crohn’s disease and infections (cytomegalovirus (CMV), nonA-nonB hepatitis, mononucleosis infectiosa, HIV).
PSA levels can also increase in benign prostatic enlargement (hyperplasia).
Chromogranin A may also be elevated in pheochromocytoma, pancreatic and prostate tumors.

Tests:

  • Tumor markers (serum test): alpha-fetoprotein (AFP), β-2-Microglobulin (B2M), free β Human Chorionic Gonadotropin (free β-HCG), chromagranin A (CgA), prostate-specific antigen (PSA), free prostate-specific antigen (PSA free)

Price of Tumor markers of the digestive system: 38 800 HUF

Package discount: 4.9 %
Type of tests 2 pcs
Number of tests 9 pcs
Időpontfoglalás

Our package, called Tumor markers of the digestive, includes laboratory measurements for tumor markers that are elevated in liver, ovarian, large intestine (colon), and pancreatic lesions.

Description:

Our package, called Tumor markers of the digestive system, includes laboratory measurements for tumor markers that are elevated in liver, ovarian, large intestine (colon), and pancreatic lesions.

Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!
A negative result does not exclude the presence of a tumor!
These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver and ovarian cancer.
Cancer antigen 19-9 (CA-19-9) may indicate the development of tumors of the pancreas, bile duct, colon, lung, gallbladder.
CA 72-4 is parameter to monitor the disease progression and the treatment of patients with gastric and ovarian cancer.

The carcinoembryonic antigen (CEA) is produced by embryonic and tumor cells. Its level can be elevated in gastrointestinal tumors as well as in case of breast, lung, liver, pancreatic and ovarian cancers.

Cancer antigen 242 (CA-242) is the tumor marker of colon- and pancreas cancers.
Elevated cancer antigen 50 (CA-50) may be the sign of gastrointestinal tumors.

Lactoferrin is an iron-binding protein that is also present in neutrophil granulocytes involved in the inflammatory immune response. Thus, its levels are measured in relation to the inflammatory processes in gastrointestinal diseases. Lactoferrin levels can also be elevated in colorectal tumors.

Calprotectin is a calcium-, zinc- and manganese-binding protein produced by neutrophil granulocytes and monocytes. Its level can also be elevated in colorectal tumors.

These tumor markers are not specific!
High AFP values can also be obtained in cases of hepatitis, cirrhosis and hepatitis.
CA 19-9 levels may also be elevated in biliary cancer, pancreatitis, cystic fibrosis and liver disease.
Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, cirrhosis and ovarian cysts).
CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.

Tests:

  • Tumor markers (serum test): alpha-fetoprotein (AFP), cancer antigen 19-9 (CA-19-9), cancer antigen 242 (CA-242), cancer antigen 50 (CA-50), cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA)
  • Stool analysis: stool blood, lactoferrin, calprotectin

Price of Tumor markers of the respiratory system: 18 900 HUF

Package discount: 5.2 %
Type of tests 1 pcs
Number of tests 4 pcs
Időpontfoglalás

Our package, called Tumor markers of the respiratory system, includes laboratory measurements for tumor markers that are elevated in lung lesions.

Description:

Our package, called Tumor markers of the respiratory, includes laboratory measurements for tumor markers that are elevated in lung lesions.

Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!
A negative result does not exclude the presence of a tumor!
These tumor markers are not specific!

For non-small cell lung cancer, CA 72-4 and CYFRA 21-1 are considered the most suitable biomarkers.
Carcinoembryonic antigen (CEA) is produced by embryonic as well as tumor cells. Its level can also be elevated in lung tumors.
The measurement of neuron-specific enolase (NSE) can be used to monitor the efficacy of therapy and to assess changes in the condition of patients with tumors, particularly small cell lung cancer and neuroblastoma.

These tumor markers are not specific!
Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, liver cirrhosis and ovarian cysts).

CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.
Elevated CYFRA 21 1 levels have also been described in non-malignant diseases (e.g. pneumonia, sepsis) and abnormal kidney function.
Elevated NSE levels may occur in malignant neuroendocrine diseases, a number of other tumors and clinical pathologies.

Tests:

  • Tumor markers (serum test): cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA), Cyfra-21-1, neuron-specific enolase (NSE)

Price of Tumor marker tests for females: 96 800 HUF

Package discount: 4,9 %
Type of tests 2 pcs
Number of tests 20 pcs
Időpontfoglalás

Our Tumor marker tests can help identify different types of tumors that most commonly affect women. The package includes laboratory measurements of tumor markers for liver, ovarian, breast, stomach, colon, pancreas and lung lesions.

Description:

Our Tumor marker tests can help identify different types of tumors that most commonly affect women. The package includes laboratory measurements of tumor markers for liver, ovarian, breast, stomach, colon, pancreas and lung lesions.

Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!
A negative result does not exclude the presence of a tumor!
These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver, ovarian and testicular cancer. Among the test parameters, cancer antigen 125 II (CA-125) may indicate ovarian tumor; cancer antigen 19-9 (CA-19-9) may indicate pancreatic, bile duct, colon, lung, or gallbladder tumor; and cancer antigen 15-3 (CA-15-3) may indicate breast, colon or lung tumor. Elevated cancer antigen 50 (CA-50) may be the sign of gastrointestinal tumors. CA 72-4 is parameter to monitor the disease progression and the treatment of patients with gastric and ovarian cancer.

β-2-microglobulin (B2M) is produced by the body’s immune system (B lymphocytes) or by tumor cells. It can also be used to diagnose certain kidney diseases (glomerular dysfunction). Its level is elevated in tumors affecting the hematopoietic system (multiple myeloma, lymphoma, B-cell chronic lymphocytic leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma).

The carcinoembryonic antigen (CEA) is produced by embryonic and tumor cells. Its level can be elevated in gastrointestinal tumors or in breast, lung, liver, pancreatic and ovarian cancers. In non-small cell lung cancer (mainly squamous cell and large cell carcinoma subtypes), CYFRA 21 1 is considered the most suitable biomarker.

Human Chorionic Gonadotropin (hCG) is produced in placental cells and plays a role in the maintenance of the corpus luteum during pregnancy. Its level is elevated from the first week after conception to 8-10 weeks, making it an excellent indicator of pregnancy. Otherwise, an elevated level may indicate ovarian, placental, pancreatic, breast or, in men, testicular tumors.

Cancer antigen 242 (CA-242) is a tumor marker for colorectal and pancreatic cancer types.

Chromogranin A (CgA) can be used to diagnose neuroendocrine tumors and to monitor therapy in treated patients. Neuroendocrine tumors can arise in almost any organ of the human body, most commonly arising from the mucosa of the gastrointestinal tract and pancreas, and the bronchial system. The concentration of chromogranin A correlates with disease activity and tumor size.

Human epididymis protein 4 (HE4) is a tumor marker for ovarian carcinomas. The determination of HE4 concentration is also useful to monitor the diagnosed and treated malignant ovarian cancer.

The SCC antigen is used for the follow-up of squamous cell carcinomas.
Pro-gastrin-releasing peptide (ProGRP) is a sensitive tumor marker of neuroendocrine cancers.

Lactoferrin is an iron-binding protein that is also present in neutrophil granulocytes involved in the inflammatory immune response. Thus, its level correlates with inflammatory processes in gastrointestinal diseases. Its level may also be elevated in colorectal tumors.

Calprotectin is a calcium-, zinc- and manganese-binding protein produced by neutrophil granulocytes and monocytes. Its level may also be elevated in colorectal tumors.

The measurement of neuron-specific enolase (NSE) can be used to monitor the efficacy of therapy and to assess changes in the condition of patients with tumors, particularly small-cell lung cancer and neuroblastoma.

The measurement of S-100 protein can be used to support the management of patients with malignant melanoma and to support the management of patients with brain injury (traumatic brain injury or stroke).

These tumor markers are not specific!
CA-125 levels can also be high during menstruation, pregnancy and pelvic inflammatory disease.
CA 19-9 levels may also be elevated in biliary cancer, pancreatitis, cystic fibrosis and liver disease.
CA 15-3 levels may also be elevated during liver and breast inflammation.
Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, liver cirrhosis and ovarian cysts).
CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.

Elevated CYFRA 21 1 levels have also been described in non-malignant diseases (e.g. pneumonia, sepsis) and abnormal kidney function.
High AFP levels may also be seen in hepatitis, cirrhosis and hepatitis.
β-2-microglobulin (B2M) level can be elevated in renal inflammation, autoimmune diseases (systemic lupus erythematosus (SLE)), rheumatoid arthritis (RA), Sjörgen’s syndrome (SjS), Crohn’s disease and infections (cytomegalovirus (CMV), nonA-nonB hepatitis, mononucleosis infectiosa, HIV).
Elevated NSE levels may also occur in malignant neuroendocrine diseases, many other tumor diseases and clinical pathologies.

Chromogranin A may also be elevated in pheochromocytoma, pancreatic and prostate tumors.

Tests:

  • Tumor markers (serum test): alpha-fetoprotein (AFP), β-2-microglobulin (B2M), cancer antigen 125 II (CA-125), cancer antigen 15-3 (CA-15-3), cancer antigen 19-9 (CA-19-9), cancer antigen 242 (CA-242), cancer antigen 50 (CA-50), cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA), chromogranin A (CgA), Cyfra-21-1, Human Chorionic Gonadotropin (HCG), neuron-specific enolase (NSE), S-100 protein, Human epididymis protein 4 (HE4), pro-gastrin-releasing peptide (ProGRP), squamous cell carcinoma (SCC) antigen
  • Stool analysis: stool blood, lactoferrin, calprotectin

Price of Tumor markers of the female reproductive system: 34 900 HUF

Package discount: 5,5 %
Type of tests 1 pcs
Number of tests 8 pcs
Időpontfoglalás

Our package, called Tumor markers of the female reproductive system, includes laboratory measurements for liver, ovarian, and neuroendocrine tumors.

Description:

Our package, called Tumor markers of the female reproductive system, includes laboratory measurements for liver, ovarian, and neuroendocrine tumors.

Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!
A negative result does not exclude the presence of a tumor!
These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver, ovarian and testicular cancer. Among the test parameters, cancer antigen 125 II (CA-125) may indicate ovarian tumor; whereas, cancer antigen 15-3 (CA-15-3) may indicate breast tumor. CA 72-4 is parameter to monitor the disease progression and the treatment of patients with gastric and ovarian cancer.

The carcinoembryonic antigen (CEA) is produced by embryonic and tumor cells. Its level can be elevated in case of breast, lung, liver, pancreatic and ovarian cancers.
Human Chorionic Gonadotropin (hCG) is produced in placental cells and plays a role in the maintenance of the corpus luteum during pregnancy. Its level is elevated from the first week after conception to 8-10 weeks, making it an excellent indicator of pregnancy. Otherwise, an elevated level may indicate ovarian, placental, pancreas or breast tumors.

Chromogranin A (CgA) can be used to diagnose neuroendocrine tumors and to monitor therapy in treated patients. Neuroendocrine tumors can arise in almost any organ of the human body, most commonly arising from the mucosa of the gastrointestinal tract and pancreas, and the bronchial system. The concentration of chromogranin A correlates with disease activity and tumor size.

Human epididymis protein 4 (HE4) is a tumor marker for ovarian carcinomas. The determination of HE4 concentration is also useful to monitor the diagnosed and treated malignant ovarian cancer.

These tumor markers are not specific!
High AFP values can also be determined in cases of hepatitis, cirrhosis and hepatitis.
CA-125 levels can also be high during menstruation, pregnancy and pelvic inflammatory disease.
CA 15-3 levels may also be elevated in liver and breast inflammation.
Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, liver cirrhosis and ovarian cysts).
CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.
Chromogranin A may also be elevated in pheochromocytoma, pancreatic and prostate tumors.

Tests:

  • Tumor markers (serum test): alpha-fetoprotein (AFP), cancer antigen 125 II (CA-125), cancer antigen 15-3 (CA-15-3), cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA), chromagranin A (CgA), Human Chorionic Gonadotropin (HCG), Human epididymis protein 4 (HE4)